Maksim O. Skarnovich
Kol'tsovo, NVS 630559, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Safety and Pharmacokinetics of the Substance of the Anti-Smallpox Drug NIOCH-14 after Oral Administration to Laboratory Animals.
Journal: Viruses
Published: November 23, 2022
Genome Features and In Vitro Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.
Journal: BioMed research international
Published: October 21, 2020
Estimation of Absolute Bioavailability of the Chemical Substance of the Anti-Smallpox Preparation NIOCH-14 in Mice.
Journal: Bulletin of experimental biology and medicine
Published: January 23, 2020
Retraction: Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
Journal: Antiviral therapy
Published: July 26, 2019
Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
Journal: Antiviral therapy
Published: November 29, 2016
New effective chemically synthesized anti-smallpox compound NIOCH-14.
Journal: The Journal of general virology
Published: February 11, 2016
Evaluation of therapeutic-prophylactic effectiveness of chemical compound NIOC-14 against ectromelia virus in vivo
Journal: Zhurnal mikrobiologii, epidemiologii i immunobiologii
Published: April 07, 2015
Efficacy of combined administration of ridostin and oseltamivir (tamiflu) for therapy and prophylaxis of experimental infection induced by influenza virus A (H5N1) in mice
Journal: Zhurnal mikrobiologii, epidemiologii i immunobiologii
Published: December 08, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026